Synthesis, cytotoxicity, QSAR, and intercalation study of new diindenopyridine derivatives

被引:78
作者
Miri, R
Javidnia, K
Hemmateenejad, B
Azarpira, A
Amirghofran, Z
机构
[1] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran
[2] Shiraz Univ Med Sci, Fac Pharm, Dept Med Chem, Shiraz, Iran
[3] Shiraz Univ Med Sci, Fac Med, Dept Immunol, Shiraz, Iran
关键词
diindenopyridine; cytotoxicity; QSAR; intercalation;
D O I
10.1016/j.bmc.2004.03.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Seven new derivatives of diindenopyridine were synthesized by Hantsch pyridine synthesis. Their biological activity to inhibit cell proliferation was assessed by MTT assay on seven cell lines. 11-(4-Fluoro-phenyl)-diindeno[1,2-b;2',1'-e]pyridine-10,12-dione and 11-(2-nitro-phenyl)-diindeno[1,2-b;,2',1'-e]pyridine-10,12-dione were active on K-562 cell line with IC50 values of 79.66 and 78.2 muM, respectively. Effect of structural parameters on the cytotoxicity was evaluated by quantitative structure activity relationship (QSAR) analysis and a linear relationship was found between the -log IC15 of these compounds and their Surface area and molar refractivity. To model the DNA-intercalator complex, force field molecular mechanic calculation was employed and the binding energy of the reaction between the intercalating agent and each reasonable double base pairs of DNA was calculated. It was found that these molecules could intercalate into the DNA. Also, it was observed that 11-(2-nitro-phenyl)-diindeno[1,2-b;2',1'-e]pyridine-10,12-dione. which showed the highest activity in K-562 cell line, produced the most negative binding energy with a moderate selectivity toward A-G/T-C double base pairs. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2529 / 2536
页数:8
相关论文
共 34 条
[1]   SYNTHESIS OF (DIALKYLAMINO)ALKYL-DISUBSTITUTED PYRIMIDO[5,6,1-DE]ACRIDINES, A NOVEL GROUP OF ANTICANCER AGENTS ACTIVE ON A MULTIDRUG-RESISTANT CELL-LINE [J].
ANTONINI, I ;
COLA, D ;
POLUCCI, P ;
BONTEMPSGRACZ, M ;
BOROWSKI, E ;
MARTELLI, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3282-3286
[2]   Synthesis and DNA interaction of a mixed proflavine-phenanthroline Troger base [J].
Baldeyrou, B ;
Tardy, C ;
Bailly, C ;
Colson, P ;
Houssier, C ;
Charmantray, F ;
Demeunynck, M .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (04) :315-322
[3]  
BARADLY PG, 1999, FARMACO, V549, P15
[4]  
BIOO J, 2001, BIOORGAN MED CHEM, V9, P1149
[5]   The roles of aromaticity in the structure of DNA and its intercalation complexes with quinones [J].
Box, VGS ;
Jean-Mary, F .
JOURNAL OF MOLECULAR MODELING, 2001, 7 (09) :334-342
[6]   Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells [J].
Dassonneville, L ;
Wattez, N ;
Baldeyrou, B ;
Mahieu, C ;
Lansiaux, A ;
Banaigs, B ;
Bonnard, I ;
Bailly, C .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (04) :527-537
[7]   Ring-substituted 11-oxo-11H-indeno[1,2-b]quinoline-6-carboxamides with similar patterns of cytotoxicity to the dual topo I/II inhibitor DACA [J].
Deady, LW ;
Desneves, J ;
Kaye, AJ ;
Thompson, M ;
Finlay, GJ ;
Baguley, BC ;
Denny, WA .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (12) :2801-2809
[8]  
Denny W A, 1988, Drug Des Deliv, V3, P99
[9]  
DENNY WA, 1989, ANTI-CANCER DRUG DES, V4, P241
[10]   Intercalation of imidazoacridinones to DNA and its relevance to cytotoxic and antitumor activity [J].
Dziegielewski, J ;
Slusarski, B ;
Konitz, A ;
Skladanowski, A ;
Konopa, J .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (09) :1653-1662